General literature
A Problem Shared: Open innovation can secure a better future for R&D because strength is found in numbers

McGuigan R.

The Medicine Maker 2018, 38. open access.

General literature
Optimization of an Azaindazole Series of CCR1 Antagonists and Development of a Semicontinuous-Flow Synthesis

Harcken C., Grant J., Razavi H., Marsini M. A., Buono F. G., Lorenz J. C., Reeves J. T.

ACS Symposium Series 2019, Vol. 1332, ISBN13: 9780841234321. open access.

DOI
General literature
Designing Effective Lead Molecules against Solid Tumors with Inadequate Treatment Options

Pantsar T.

UNIVERSITY OF EASTERN FINLAND Electronic Publication 2018, ISBN 978-952-61-2748-4. open access.

General literature
Chemically induced degradation of the transcription factor BCL6

Kerres N., Steurer S., Schlager S., Bader G., Berger H., Caligiuri M., Dank C., Engen JR., Ettmayer P., Fischerauer B., Flotzinger G., Gerlach D., Gerstberger T., Gmaschitz T., Greb P., Han B., Heyes E., Iacob RE., Kessler D., Kölle H., Lamarre L., Lancia DR., Lucas S., Mayer M., Mayr K., Mischerikow N., Mück K., Peinsipp C., Petermann O., Reiser U., Rudolph D., Rumpel K., Salomon C., Scharn D., Schnitzer R., Schrenk A., Schweifer N., Thompson D., Traxler E., Varecka R., Voss T., Weiss-Puxbaum A., Winkler S., Zheng X., Zoephel A., Kraut N., McConnell D., Pearson M., Koegl M.

Cancer Research 2017, 20 (12), 2860-2875. open access

DOI
PUBMED
Success examples
Mechanistic MALDI-TOF Cell-Based Assay for the Discovery of Potent and Specific Fatty Acid Synthase Inhibitors

Weigt D., Parrish CA., Krueger JA., Oleykowski CA., Rendina AR., Hopf C.

Cell Chemical Biology 2019, 26, 1322-1331 E4. open access

FAS inhibitor
DOI
PUBMED
General literature
Mechanistic MALDI-TOF Cell-Based Assay for the Discovery of Potent and Specific Fatty Acid Synthase Inhibitors

Weigt D., Parrish CA., Krueger JA., Oleykowski CA., Rendina AR., Hopf C.

Cell Chamical Biology 2019, pii: S2451-9456(19)30205-3. open access

DOI
PUBMED